Sevelamer Carbonate 400 mg is an oral phosphate-binding agent used in the management of hyperphosphatemia (high phosphate levels in the blood), particularly in patients with chronic kidney disease (CKD) on dialysis. It belongs to the class of non-calcium, non-metal phosphate binders. Sevelamer Carbonate works by binding dietary phosphate in the gastrointestinal tract, preventing its absorption into the bloodstream. This helps reduce serum phosphorus levels and lowers the risk of complications such as bone disorders, vascular calcification, and cardiovascular issues associated with chronic kidney disease. Unlike calcium-based phosphate binders, Sevelamer Carbonate does not increase calcium levels, making it suitable for patients who need to avoid hypercalcemia.
